Homo sapiens Protein: PIK3C2A | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||
InnateDB Protein | IDBP-33680.5 | ||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||
Gene Symbol | PIK3C2A | ||||||||||||||||||||||||||
Protein Name | phosphoinositide-3-kinase, class 2, alpha polypeptide | ||||||||||||||||||||||||||
Synonyms | CPK; PI3-K-C2(ALPHA); PI3-K-C2A; | ||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||
Ensembl Protein | ENSP00000265970 | ||||||||||||||||||||||||||
InnateDB Gene | IDBG-33678 (PIK3C2A) | ||||||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||
Function | Generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act as second messengers. Has a role in several intracellular trafficking events. Functions in insulin signaling and secretion. Required for translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane and glucose uptake in response to insulin- mediated RHOQ activation. Regulates insulin secretion through two different mechanisms: involved in glucose-induced insulin secretion downstream of insulin receptor in a pathway that involves AKT1 activation and TBC1D4/AS160 phosphorylation, and participates in the late step of insulin granule exocytosis probably in insulin granule fusion. Synthesizes PtdIns3P in response to insulin signaling. Functions in clathrin-coated endocytic vesicle formation and distribution. Regulates dynamin- independent endocytosis, probably by recruiting EEA1 to internalizing vesicles. In neurosecretory cells synthesizes PtdIns3P on large dense core vesicles. Participates in calcium induced contraction of vascular smooth muscle by regulating myosin light chain (MLC) phosphorylation through a mechanism involving Rho kinase-dependent phosphorylation of the MLCP-regulatory subunit MYPT1. May play a role in the EGF signaling cascade. May be involved in mitosis and UV-induced damage response. Required for maintenance of normal renal structure and function by supporting normal podocyte function. {ECO:0000269PubMed:10766823, ECO:0000269PubMed:10805725, ECO:0000269PubMed:11239472, ECO:0000269PubMed:12719431, ECO:0000269PubMed:16215232, ECO:0000269PubMed:21081650, ECO:0000269PubMed:9337861}. | ||||||||||||||||||||||||||
Subcellular Localization | Cell membrane. Golgi apparatus. Cytoplasmic vesicle, clathrin-coated vesicle. Nucleus. Cytoplasm. Note=According to PubMed:10766823 and PubMed:11239472, it is found in the cell membrane, the Golgi apparatus and in clathrin-coated vesicles. According to PubMed:17038310 it inserts preferentially into membranes containing PtdIns(4,5)P2. According to PubMed:11606566, it is nuclear and cytoplasmic. Associated with RNA-containing structures. According to PubMed:14563213, it is mainly cytoplasmic. | ||||||||||||||||||||||||||
Disease Associations | |||||||||||||||||||||||||||
Tissue Specificity | Expressed in columnar and transitional epithelia, mononuclear cells, smooth muscle cells, and endothelial cells lining capillaries and small venules (at protein level). Ubiquitously expressed, with highest levels in heart, placenta and ovary, and lowest levels in the kidney. Detected at low levels in islets of Langerhans from type 2 diabetes mellitus individuals. {ECO:0000269PubMed:14563213, ECO:0000269PubMed:21127054, ECO:0000269PubMed:9337861}. | ||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 22 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||
InterPro |
IPR000008
C2 domain IPR000341 Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain IPR000403 Phosphatidylinositol 3-/4-kinase, catalytic domain IPR001263 Phosphoinositide 3-kinase, accessory (PIK) domain IPR001683 Phox homologous domain IPR002420 Phosphatidylinositol 3-kinase, C2 domain IPR011009 Protein kinase-like domain IPR016024 Armadillo-type fold IPR029071 Ubiquitin-related domain |
||||||||||||||||||||||||||
PFAM |
PF00168
PF00794 PF00454 PF00613 PF00787 PF00792 |
||||||||||||||||||||||||||
PRINTS |
PR00360
|
||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||
SMART |
SM00239
SM00144 SM00146 SM00145 SM00312 SM00142 |
||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||
SwissProt | O00443 | ||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-O00443 | ||||||||||||||||||||||||||
TrEMBL | L7RRS0 | ||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||
Entrez Gene | 5286 | ||||||||||||||||||||||||||
UniGene | Hs.713166 | ||||||||||||||||||||||||||
RefSeq | NP_002636 | ||||||||||||||||||||||||||
HUGO | HGNC:8971 | ||||||||||||||||||||||||||
OMIM | 603601 | ||||||||||||||||||||||||||
CCDS | CCDS7824 | ||||||||||||||||||||||||||
HPRD | 04672 | ||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||
EMBL | AC107956 AC116533 AC126389 BC113658 CH471064 EU332862 JX512454 Y13367 | ||||||||||||||||||||||||||
GenPept | AAI13659 ABY87551 AGC09601 CAA73797 EAW68447 | ||||||||||||||||||||||||||